Recently, several reports have shown that aberrantly expressed KIF2A is detected in several cancers, including breast, oral, colorectal, and ovarian cancers, and its expression contributes to cancer cell malignancies [42,43,44,45]. The gene discussed is KIF2A; the disease is ovarian carcinoma.